Risk assessment of chemical carcinogens and thresholds

References

• American Conference of Governmental Hygenist. (2004). TLVs and BEIs. Threshold Limit Values and Biological Exposure Indices. ACGIH, Cincinnaty, USA.
   Google Scholar
• American Industrial Health Council. (1981). Annual newsletter.
   Google Scholar
• Aldridge, W.N. (1995). Defining thresholds in occupational and environmental toxicity. Toxicol. Lett. 77: 109–118.
   PubMed Web of Science ®Google Scholar
• Bernheim, N.J., and Falk, H. (1981). Chemical, physical and genetic factors interfering with DNA repair—A review. J. Am. Coll. Toxicol. 2: 23–54.
   Google Scholar
• Bitsch, A., Deubelbeiss, C., and Greiner, A. (1999). c-fos gene expression in rat liver is induced by phenobarbital. Cancer Lett. 135: 215–122.
   PubMed Web of Science ®Google Scholar
• Bitsch, A., Hadjiolov, N., Klöhn, P.C., Bergmann, O., Zwirner-Baier, I., and Neumann, H.G. (2000). Dose-response of early effects related to tumor promotion of 2-acetylaminofluorene. Toxicol. Sci. 55: 44–51.
   PubMed Web of Science ®Google Scholar
• Bridges, B.A., and Stamper, J.G. (1975). Hypothetical Dose-response curves for chronic exposures to mutagens or carcinogens subject to simple enzymatic detoxification in the mammalian body. Mutat. Res. 33:87–91.
   PubMedGoogle Scholar
• Broccardo, C.J., Billings, R.E., Chubb, L.S., Andersen, M.E., and Hannemann, W.H. (2004). Single Cell analysis of switch-like induction of CYP1A1 in liver cell lines. Toxicol. Sci. 78:287–294.
   PubMed Web of Science ®Google Scholar
• Burnet, F.M. (1976). Mutation, somatische Mutation und Krankheit beim Menschen. Naturw. Rdsch. 29: 305–311.
   Google Scholar
• Butterworth, B.E., and Bogdanffy, M.S. (1999). A comprehensive approach for integration of toxicity and cancer risk assessment. Regul. Toxicol. Pharmacol. 29:23–36.
   PubMed Web of Science ®Google Scholar
• Claus, G. (1974). Environmental carcinogenesis; Is there a threshold of exposure. Clin. Toxicol. 7: 497–508.
   PubMed Web of Science ®Google Scholar
• Claus, G., Krisko, I., and Bolander, K. (1974). Chemical carcinogens in the environment and the human diet: Can a threshold be established. Food Cosmet. Toxicol. 12: 737–746.
   PubMedGoogle Scholar
• Clayson, D.B. (1978). Overview, myth and speculation. J. Environ. Pathol. Toxicol. 2:1–8.
   PubMedGoogle Scholar
• Cox, C. (1987). Threshold dose-response models in toxicology. Biometrics 43: 511–523.
   PubMed Web of Science ®Google Scholar
• Crump, K.S., Hoel, D.G., Langley, C.H., and Peto, R. (1976). Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 36: 2973–2979.
   PubMed Web of Science ®Google Scholar
• Diaz Gomez, M.I., Swann, P.F., and Magee, P. (1977). The absorption and metabolism in rats of small oral doses of dimethylnitrosoamine. Biochem. J. 164: 497–500.
   PubMed Web of Science ®Google Scholar
• Druckrey, H. (1943). Quantitative Grundlagen der Krebserzeugung. Klin. Wochenschrift 22: 532–534.
   Google Scholar
• Druckrey, H. (1959). Pharmacological approach to carcinogenesis. In: Ciba Foundation Symposium on Carcinogenesis, Mechanisms of Action, Wolstenholm G.E.W., O´Connor M (Hrsg.), L&A Churchill Ltd. Gloucester, Great Britain, pp. 110–130.
   Google Scholar
• Druckrey, H., Schmähl. D., Dischler, W., and Schildbach, A. (1962). Quantitative Analyse der experimentellen Krebserzeugung. Naturwissenschaften 49: 217–228.
   Web of Science ®Google Scholar
• Dunn, B.P. (1983). Wide range linear dose-response curve for DNA binding of orally administered benzo(a)pyrene in mice. Cancer Res. 43:2654–2658.
   PubMed Web of Science ®Google Scholar
• Edler, L., Porti, C.J., and Kopp-Schneider, A. (1994). Zur Existenz von Schwellenwerten: Wissenschaftliche Methode oder statistisches Artefakt in der Risikoabschätzung. Zbl. Arbeitsmed. 44: 16–21.
   Google Scholar
• EU-Bericht v. 26.10. (2000). First Report on the Harmonisation of Risk Assessment Procedures. 2. Appendices.
   Google Scholar
• Farmer, J.H., Kodell, R.L., Greenman, D.L., and Shaw, G.W. (1979). Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol. 3: 55–68.
   Google Scholar
• Hanahan, D., and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100: 57–70.
   PubMed Web of Science ®Google Scholar
• Hart, R.W., and Frame, L.T. (1996). Toxicological defense mechanism and how they may affect the nature of dose-response relationships. Belle Newslett. 5:1–16.
   Google Scholar
• Haseman, J.K. (2003). An alternative perspective: a critical evaluation of the Waddell threshold extrapolation model in chemical carcinogenesis. Toxicol. Pathol. 31: 712–713.
   PubMed Web of Science ®Google Scholar
• HBM-Kommission, Stellungnahme. (2003). Verwendung von Hämoglo binaddukten als Biomarker für das Monitoring von Belastungen und Beanspruchungen durch gentoxische Stoffe. Bundesgesund. Gesundheits. Gesundheitsschutz. 46: 918–922.
   Google Scholar
• Hecker, E., and Rippman, F. (1988). Quantitative determination of experimental threshold doses (no-effect levels) for environmental promoters in the initiation/promotion protocol on skin of NRMI mice. Naunyn-Schmiedebergs Arch. Pharmacol. 338(Suppl. R11).
   Google Scholar
• Henschler, D. (1973a). Veränderungen der Umwelt—Toxikologische Probleme. Angew. Chem. 85: 317–326.
   Google Scholar
• Henschler, D. (1973b), Toxicological problems relating to changes in the environment. Angew. Chem. Int. Ed. Engl. 12: 274–282.
   PubMed Web of Science ®Google Scholar
• Henschler, D. (1974). New approaches to a definition of threshold values for irreversible effects. Arch. Toxicol. 32: 63–67.
   PubMed Web of Science ®Google Scholar
• Hooper, N.K., Harris, R.H., and Ames, B.N. (1979). Letters. Chemical carcinogens. Science 203: 602–603.
   PubMedGoogle Scholar
• Ito, N., Imaida, K., Hasegawa, R., and Tsuda, H. (1988) Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats—An approach for a new medium-term bioassay system. Carcinogenesis 9: 387–394.
   PubMed Web of Science ®Google Scholar
• Jackson, C.D., Weis, C., and Shellenberger, T.E. (1980). Tissue binding of 2-acetylaminofluorene in BALB/c and C57Bl/6 mice during chronic oral administration. Chem. Biol. Interact. 32: 63–81.
   PubMed Web of Science ®Google Scholar
• Kisch-Volders, M., Aaredema, M., and Elhajoiji, A. (2000). Concepts of thresholds in mutagenesis and carcinogenesis. Mutat. Res. 464:3–11.
   PubMed Web of Science ®Google Scholar
• Kitano, M., Ichihara, T., Matsuda, T., Wanibuchi, H., Tamano, S., Hagiwara, A., Imaoka, S., Funae, Y., Shirai, T., and Fukushoma, S. (1998). Presence of a threshold for promoting effects of phenobarbital on diethylnitrosamine-induced hepatic foci in the rat. Carcinogenesis 19: 1475–1480.
   PubMed Web of Science ®Google Scholar
• Klöhn, P.C., Bitsch, A., and Neumann, H.G. (1998). Mitochondrial permeability transition is altered in early stages of carcinogenesis of 2-acetylaminofluorene. Carcinogenesis 19: 1185–1190.
   PubMed Web of Science ®Google Scholar
• Koelle, G.B. (1977). The zero-tolerance concept. Perspect. Biol. Med. 20: 507–509.
   PubMed Web of Science ®Google Scholar
• Kunz, H.W., Tennekes, H.A., Port, R.E., Schwartz, M., Lorke, D., and Schaude, O. (1983). Quantitative aspects of chemical carcinogenesis and tumor promotion in liver. Environ. Health Perspect. 50: 113–122.
   PubMed Web of Science ®Google Scholar
• Lewalter, J., and Neumann, H.G. (1998). Background exposure of persons not occupationaly exposed to chemicals, in: Deutsche Forschungsgemeinschaft, Greim, H., Lehnert, G., (edts.), Biological exposure values for occupational toxicants and carcinogens, Vol. 3. Wiley-VCH, Weinheim, pp. 3–34.
   Google Scholar
• Lutz, W.K., and Fekete, T. (1996). Endogenous and exogenous factors in carcinogenesis: Limits to cancer prevention. Int. Arch. Occup. Environ. Health 68: 120–125.
   PubMed Web of Science ®Google Scholar
• Lutz, W.K., and Gaylor, D. (1996). Significance of DNA adducts at low dose: Shortening the time to spontaneous tumor occurrence. Regul. Toxicol. Pharmacol. 23: 29–34.
   PubMed Web of Science ®Google Scholar
• Lutz, W.K., and Kopp-Schneider, A. (1999). Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay. Toxicol. Sci. 49: 110–115.
   PubMed Web of Science ®Google Scholar
• Lutz, W.K., Beland, P.E., Candrian, R., Fekete, T., and Fischer, W.H. (1996). Dose-time response in mouse skin tumor induction by 7,12-dimethylbenz(a)anthracene and 12-O-tetradecanoyl-phorbol 13-acetate. Regul. Toxicol. Pharmacol. 23: 44–48.
   PubMed Web of Science ®Google Scholar
• Lutz, W.K., and Schlatter, C. (1978). Extrapolation of carcinogenicity data to low doses with a dose–response study of the binding of benzo(a)pyrene to rat liver DNA. Arch. Toxicol. Suppl 1: 369–371.
   Google Scholar
• MAK-und BAT-Werte-Liste. (2004). Senatskommission zur Prüfung gesundheitsschädlicher Arbeitsstoffe, DFG. Wiley-Verlag, Weinheim
   Google Scholar
• Mantel, N., and Schneiderman, M.A. (1975). Estimating “safe” levels, A hazardous undertaking. Cancer Res. 35: 1379–1386.
   PubMed Web of Science ®Google Scholar
• Mastromatteo, E. (1981). On the concept of threshold. Am. Ind. Hyg. Assoc. J. 42: 763–770.
   PubMed Web of Science ®Google Scholar
• Maugh, T.H. II. (1978). Chemical carcinogens: How dangerous are low doses. Science 202: 37–41.
   PubMed Web of Science ®Google Scholar
• Miller, J.A., and Miller, E.C. (1971). Chemical carcinogenesis: Mechanisms and approaches to its control. Guest editorial. J. Natl. Cancer Inst. 47: V–XIV.
   PubMedGoogle Scholar
• Montesano, R. (1981). Alkylation of DNA and tissue specificity in nitrosamne carcinogenesis. J. Supramol. Structure Cell.Biochem. 17: 259–273.
   PubMedGoogle Scholar
• Neumann, H.G. (1973). Ultimale elektrophile Carcinogene und nukleophile Reaktanten der Zelle. Vortrag: 14, Frühjahrstagung der DGPT, 18.–21.3. Mainz.
   Google Scholar
• Neumann, H.G. (1974). Ultimate electrophillic carcinogens and cellular nucleophilic reactants. Arch. Toxicol. 32: 27–38.
   PubMed Web of Science ®Google Scholar
• Neumann, H.G., Baur, H., and Wirsing, R. (1980). Dose-response relationship in the primary lesion of strong electrophilic carcinogens. In: Quantitative aspects of risk assessment in chemical carcinogenesis. Arch. Toxicol. Suppl. 3: 69–77, discussion 145–147.
   Google Scholar
• Oesch, F., Herrero, M.E., Hengstler, J.G., Lohmann, M., and Arand, M. (2000). Metabolic detoxification; implications for thresholds. Toxicol. Pathol. 28: 382–387.
   PubMed Web of Science ®Google Scholar
• Park, C.N., and Snee, E.D. (1983). Quantitative risk assessment: State of the art for carcinogenesis. Fundam. Appl. Toxicol. 3: 320–333.
   PubMedGoogle Scholar
• Paynter, O.E., Burin, G.J., Jaeger, R.B., and Gregorio, C.A. (1988). Goitrogens and thyroid follicular cell neoplasia: Evidence for a threshold process. Regul. Toxicol. Pharmacol. 8: 102–119.
   PubMed Web of Science ®Google Scholar
• Pitot, H.C., and Campbell, H.A. (1988). Quantitative studies on multistage hepatocarcinogenesis in the rat. In: Langenbach, R. et al. (edts.), Tumor promoters: Biological approaches for mechanistic studies and assay systems. Raven Press, New York, pp. 79–95
   Google Scholar
• Poirier, M.C., Fullerton, N.F., Kinouchi, T., Smith, B.A., and Beland, F.A. (1991). Comparison between DNA adduct formation and tumorigenicity in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis 12: 895–900.
   PubMed Web of Science ®Google Scholar
• Pong, R.S., and Wogan, G.N. (1970). Time course and dose-response characteristics of aflatoxin B1 Effects on rat liver DNA polymerase and ultrastructure. Cancer Res. 30: 294–304.
   PubMed Web of Science ®Google Scholar
• Ramsey, J.C., and Gehring, P.J. (1980). Application of pharmacokinetic principles in practice. Fed. Proc. 39: 60–65.
   PubMedGoogle Scholar
• Risiko Kommission. (2003). Ad Hoc Kommission“Neuordnung der Verfahren und Strukturen zur Risikobewertung und Standardsetzung im gesundheitlichen Umweltschutz in der Bundesrepublik Deutschland.” Abschlussbericht 2003.
   Google Scholar
• Roach, S.A., and Rappaport, S.M. (1990). But they are not thresholds: A critical analysis of the documentation of threshold limit values. Am. J. Ind. Med. 17: 727–753.
   PubMed Web of Science ®Google Scholar
• Rozman, K.K. (2003). Thresholds in carcinogenicity in EDO1 study. Toxicol. Sci. 75: 224–225.
   PubMedGoogle Scholar
• Schaeffer, D. (1983). Thresholds for carcinogenesis and their significance to medical practice. Med. Hypoth. 10: 175–184.
   PubMed Web of Science ®Google Scholar
• Schneiderman, M.A., and Brown, C.C. (1978). Estimating cancer risk to a population. Environ. Health Perspect. 22: 115–124.
   Google Scholar
• Schulte-Hermann, R., Grassl-Kraupp, B., and Bursch, W. (2000). Dose-response and threshold effects in cytotoxicity and apoptosis. Mutat. Res. 464: 13–18.
   PubMed Web of Science ®Google Scholar
• Science and Judgment. (1994). National Research Council, National Academy Press, Washington, DC.
   Google Scholar
• Scott-Appleton, B., Goetchius, M.P., and Campbell, T.C. (1982). Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures. Cancer Res. 42: 3659–3662.
   PubMed Web of Science ®Google Scholar
• Seiler, J.P. (1977). Apparent and real thresholds. Progress in genetic toxicology. Elsevier/North Holland Biomedical Press, Amsterdam, pp. 233–238.
   Google Scholar
• Stockinger, H.E. (1972). Concepts of thresholds in standards setting. Arch. Environ. Health 25: 153–157.
   PubMedGoogle Scholar
• Swarts, J.B., Riddlough, C.R., and Epstein, S.S. (1982). Analysis of carcinogenic dose-response relations with dichotomous data: Implications for carcinogenic risk assessment. Teratogen. Carcinogen. Mutagen. 2:179–204.
   PubMedGoogle Scholar
• Travis, C.C., Zeng, C., and Nicholas, J. (1996). Biological model of ED01 hepatocarcinogenesis. Toxicol. Appl. Pharmacol. 140: 19–29.
   PubMed Web of Science ®Google Scholar
• Tritscher, A.M., Goldstein, J.A., Portier, C.J., McCoy, Z., Clark, G.C., and Lucier, G.W. (1992). Dose response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalisation of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52: 3436–3442.
   PubMed Web of Science ®Google Scholar
• Waddell, W.J. (2003). Thesholds of carcinogenicity in the EDO1 study. Toxicol. Sci. 72:158–163.
   PubMed Web of Science ®Google Scholar
• Williams, G.M. (1987). Definition of a human cancer hazard. In: Butterworth, B.E., and Slaga, T. (edts.), Nongenotoxic mechanisms in carcinogenesis, 25th Banbury Report, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
   Google Scholar
• Wolf, F.J. (1980). Effect of overloading pathways on toxicity. J. Environ. Pathol. Toxicol. 3: 113–134.
   PubMedGoogle Scholar
• Yamasaki, H. (1988). Multistage carcinogenesis: Implications for risk estimation. Cancer Metastasis Rev. 7: 5–18.
   PubMed Web of Science ®Google Scholar
• Yamasaki, H., and Weinstein, L.B. (1982). Cellular and molecular mechanisms of tumor promotion and their implications with respect to risk assessment. SGCMSEC Workshop on qnantitative estimation of risk to human health from chemicals, in Rome. Cf. Vouk, V.B., Hoel, G.C., and Peakall, D.B. (edts.), Methods for estimating risk of chemical injury: Human and non-human biota and ecosystems. John Wiley, New York, 1985, pp. 155–180.
   Google Scholar
• Zeise, L., Wilson, R., and Crouch, E.A.C. (1987). Dose-response relationships for carcinogens: A review. Environ. Health Perspect. 73: 259–308.
   PubMed Web of Science ®Google Scholar
• Zerban, H., Preussmann, R., and Bannasch, P. (1988). Dose-time relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethylnolamine. Carcinogenesis 9: 607–610.
   PubMed Web of Science ®Google Scholar